Countries that embrace legal regulation find themselves in breach of international law. In this video, we explain a strategy to resolve those treaty tensions and to enable progressive and sustainable change at the global level.
John Walsh, Ann Fordham, Martin Jelsma, Hannah Hetzer
22 September 2018
The "Global Call to Action" document that the U.S. government is circulating—and heavily pressuring reluctant countries to sign—is explicitly “not open for negotiation.” Far from an effort at achieving mutual understanding and genuine consensus, it is an instance of heavy-handed U.S. “with us or against us” diplomacy.
Today, on the United Nations’ International Day Against Drug Abuse and Illicit Trafficking (26th June), governments around the world are commemorating their decades-long support of the global war on drugs.
On 28 May 2018, the Transnational Institute and the Epicurus Foundation co-hosted the second edition of the “The Transparent Chain,” a conference on transparent cannabis supply chains in Utrecht, Netherlands.
TNI's Prof. Dave Bewley-Taylor recently delivered a statement on how states can reconcile treaty obligations with democratically mandated policy shifts at the national level to a legally regulated cannabis market, with due regard for international law, and what role the International Narcotics Control Board can play in this process.
The international dimensions of Bill C-45 are of utmost importance not only for Canada itself but for many countries around the world that are moving in the direction of legally regulating the cannabis market
The admission by UN's lead agency for drugs, the UNODC, that “the drug market is thriving” in its 2017 World Drug Report is an important one given that it is months away from 2019 – the target date by which governments committed to “significantly reduce or eliminate” the global drug market. At the recent annual gathering of the Commission on Narcotic Drugs (CND) in Vienna, this abysmal failure to claim any progress towards these ‘drug-free’ targets was the backdrop to the latest round of tense negotiations on global drug control.
David Bewley-Taylor, Tom Blickman, Martin Jelsma, John Walsh
03 April 2018
Ever since the introduction of Bill C-45, questions have been swirling concerning Canada’s position relative to the UN drug control conventions: conventions to which Canada is a party and that, crucially, prohibit the creation of regulated markets for the recreational use of cannabis.
As a growing number of countries move towards legal regulation for non-medical cannabis, governments are pushing the boundaries of the three UN drug control treaties. At the 61st session of the Commission on Narcotic Drugs (CND), TNI co-organised a side event to explore the issue, addressing the various challenges and opportunities involved.
Martin Jelsma, Neil Boister, David Bewley-Taylor, Malgosia Fitzmaurice, John Walsh
15 March 2018
Legal tensions are growing within the international drug control regime as increasing numbers of member states move towards or seriously consider legal regulation of the cannabis market for non-medical purposes. Amongst reform options not requiring consensus, inter se modification appears to be the most ‘elegant’ approach and one that provides a useful safety valve for collective action to adjust a treaty regime arguably frozen in time.
As a growing number of countries move towards legal regulation for non-medical cannabis, governments are pushing the boundaries of the three UN drug control treaties. At the 61st session of the Commission on Narcotic Drugs (CND), TNI will co-organise a side event to explore the issue, addressing the various challenges and opportunities involved.
Jamie Bridge, Martin Jelsma, Tom Blickman, Marie Nougier, David Bewley-Taylor, Christopher Hallam
29 September 2017
Diplomatic processes at the United Nations are notoriously slow and difficult, perhaps increasingly so in a modern world of multi-polar geopolitics and tensions. This is certainly no different for the highly charged and provocative issue of international drug control.
The legal approach to coca has been one of the most challenging topics in the current international drug control system, due to the plant’s connection to both commercial cocaine and ancient Andean traditions. Yet it’s rare for a case related to the coca leaf to come before a European court, in a region where those traditions are rarely discussed.
We are calling for applications from those working in sectors related to drug policy in order to increase their understanding of international drug policy reform issues, to improve their advocacy skills, and to enhance their capacity in working with the media on drug policy.
The UN General Assembly Special Session (UNGASS) on drugs – held in New York in April 2016 – was hailed as an opportunity for the international community ‘to conduct a wide-ranging and open debate that considers all options’. Although the UNGASS was characterised by many shortcomings and disappointments, it was nonetheless a critical moment for global drug policy reform.